Keio University

News

401-410 items (total 704)
Published on October 25, 2022

Measurement of Red Blood Cell Parameters and BRCA1/2 Gene Mutations Before Treatment Can Predict Severe Anemia Caused by Olaparib, a Standard Cancer Therapy - A Step Toward Early Detection and Treatment Management of "High-Risk Patients" -

Office of Communications and Public Relations

Published on October 21, 2022

KMD Forum 2022 “WonderLand” to be Held

Office of Communications and Public Relations

Published on October 20, 2022

World's First Discovery: Crows Exhibit Unique Physiological Responses When Encountering Formidable Opponents

Office of Communications and Public Relations

Published on October 18, 2022

Announcing Research Findings on the Paleo-diet of Sika Deer from the Jomon Period

Office of Communications and Public Relations

Published on October 17, 2022

Successful Observation of Magnetoresistance Effect at Room Temperature in Magnetic Nanodevices with Sandwiched Molecules—Pioneering a New Interdisciplinary Field Merging "Nanoscience," "Spin," and "Molecules"

Office of Communications and Public Relations

Published on October 14, 2022

Brain-Tech Guidebook Released—Toward a Society Where Brain-Tech Can Be Correctly Understood and Used Safely—

Office of Communications and Public Relations

Published on October 13, 2022

Keio Becomes First Private University to Be Selected under World Premier International Research Center Initiative

Office of Communications and Public Relations

Published on October 13, 2022

Combined Use of Amyloid and Tau PET Scans May Significantly Improve Diagnosis and Treatment in Dementia Care

Office of Communications and Public Relations

Published on October 12, 2022

Successful Ultra-Narrow Linewidth Carbon Nanotube Emission Using On-Chip Silica Resonators

Office of Communications and Public Relations

Published on October 11, 2022

Control of Scleral Endoplasmic Reticulum Stress Suppresses the Onset and Progression of Myopia—Elucidating the Mechanism of Myopia Progression and Raising Hopes for the Creation of New Therapeutic Drugs for Myopia

Office of Communications and Public Relations